Carole L. Wallis

4.2k total citations
82 papers, 2.2k citations indexed

About

Carole L. Wallis is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Carole L. Wallis has authored 82 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Infectious Diseases, 55 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Carole L. Wallis's work include HIV/AIDS drug development and treatment (58 papers), HIV/AIDS Research and Interventions (56 papers) and HIV Research and Treatment (55 papers). Carole L. Wallis is often cited by papers focused on HIV/AIDS drug development and treatment (58 papers), HIV/AIDS Research and Interventions (56 papers) and HIV Research and Treatment (55 papers). Carole L. Wallis collaborates with scholars based in South Africa, United States and Netherlands. Carole L. Wallis's co-authors include Wendy Stevens, Tobias F. Rinke de Wit, Kim Sigaloff, Raph L Hamers, Margaret Siwale, John W. Mellors, Cissy Kityo, Kishor Mandaliya, Akin Osibogun and François Venter and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Carole L. Wallis

81 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carole L. Wallis South Africa 26 1.9k 1.5k 466 151 99 82 2.2k
Raph L Hamers Netherlands 32 2.4k 1.2× 1.9k 1.3× 585 1.3× 207 1.4× 91 0.9× 103 2.9k
Philippe Clevenbergh France 19 1.4k 0.7× 1.0k 0.7× 492 1.1× 67 0.4× 131 1.3× 63 2.2k
F Mulcahy Ireland 19 800 0.4× 316 0.2× 594 1.3× 68 0.5× 81 0.8× 66 1.4k
Dwip Kitayaporn Thailand 24 895 0.5× 623 0.4× 812 1.7× 163 1.1× 137 1.4× 56 1.6k
Suna Balkan France 23 717 0.4× 315 0.2× 419 0.9× 142 0.9× 128 1.3× 55 1.7k
Ferdinand W N M Wit Netherlands 22 1.4k 0.7× 910 0.6× 550 1.2× 136 0.9× 195 2.0× 43 2.1k
Susan E. Buskin United States 24 1.4k 0.8× 397 0.3× 1.2k 2.5× 291 1.9× 72 0.7× 74 2.0k
Kristine B. Patterson United States 26 1.7k 0.9× 1.0k 0.7× 655 1.4× 245 1.6× 52 0.5× 60 2.2k
Awewura Kwara United States 26 1.1k 0.6× 331 0.2× 696 1.5× 129 0.9× 77 0.8× 86 1.6k
Wondwossen Amogne Ethiopia 21 667 0.4× 251 0.2× 414 0.9× 87 0.6× 91 0.9× 96 1.6k

Countries citing papers authored by Carole L. Wallis

Since Specialization
Citations

This map shows the geographic impact of Carole L. Wallis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole L. Wallis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole L. Wallis more than expected).

Fields of papers citing papers by Carole L. Wallis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole L. Wallis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole L. Wallis. The network helps show where Carole L. Wallis may publish in the future.

Co-authorship network of co-authors of Carole L. Wallis

This figure shows the co-authorship network connecting the top 25 collaborators of Carole L. Wallis. A scholar is included among the top collaborators of Carole L. Wallis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole L. Wallis. Carole L. Wallis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venter, François, Nectarios Papavarnavas, Pauline Howell, et al.. (2023). Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis: Updated recommendations. Southern African Journal of HIV Medicine. 24(1). 1522–1522. 3 indexed citations
2.
Roy, Jason, Michael Z. Levy, Carole L. Wallis, et al.. (2021). Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis. AIDS Patient Care and STDs. 35(12). 467–473. 2 indexed citations
3.
Drain, Paul K., Sean R. Galagan, Sabina Govere, et al.. (2021). Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(5). 1205–1213. 6 indexed citations
4.
Bekker, Linda‐Gail, Dvora Joseph Davey, Katherine Gill, et al.. (2020). Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020. Southern African Journal of HIV Medicine. 21(1). 1152–1152. 28 indexed citations
5.
Drain, Paul K., Ting Hong, Meighan Krows, et al.. (2019). Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa. Scientific Reports. 9(1). 2687–2687. 17 indexed citations
6.
Aitken, Susan C., Carole L. Wallis, Wendy Stevens, Tobias Rinke de Wit, & Rob Schuurman. (2015). Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping. PLoS ONE. 10(7). e0131541–e0131541. 22 indexed citations
7.
Penrose, Kerri J., et al.. (2014). High Prevalence of Cross-resistance to Rilpivirine in Subtype C HIV-1 Isolates from First-line ART Failures in South Africa. AIDS Research and Human Retroviruses. 30(S1). A166–A166. 3 indexed citations
8.
Bezemer, Daniela, Nuno R. Faria, Amin S. Hassan, et al.. (2013). HIV Type 1 Transmission Networks Among Men Having Sex with Men and Heterosexuals in Kenya. AIDS Research and Human Retroviruses. 30(2). 118–126. 32 indexed citations
9.
Calder, Alistair, et al.. (2012). HIGH RESOLUTION COMPUTED TOMOGRAPHY (HRCT) IN ONE YEAR OLD CF NEWBORN SCREENED (NBS) INFANTS: NOT A USEFUL OUTCOME MEASURE. UCL Discovery (University College London). 2 indexed citations
10.
Hamers, Raph L, Kim Sigaloff, Annemarie M. J. Wensing, et al.. (2012). Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies. Clinical Infectious Diseases. 54(11). 1660–1669. 137 indexed citations
11.
Hughes, Michael D., Beatriz Grinsztejn, Ann C. Collier, et al.. (2012). Genotype assays and third-line ART in resource-limited settings. AIDS. 26(9). 1083–1093. 23 indexed citations
12.
Bartlett, John, Heather J. Ribaudo, Carole L. Wallis, et al.. (2012). Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS. 26(11). 1345–1354. 32 indexed citations
13.
Sigaloff, Kim, et al.. (2011). Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa. AIDS Research and Human Retroviruses. 28(2). 171–175. 54 indexed citations
14.
Sigaloff, Kim, Raph L Hamers, Carole L. Wallis, et al.. (2011). Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(1). 23–31. 151 indexed citations
15.
Hamers, Raph L, Carole L. Wallis, Cissy Kityo, et al.. (2011). HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. The Lancet Infectious Diseases. 11(10). 750–759. 228 indexed citations
16.
Hamers, Raph L, Rob Schuurman, Kim Sigaloff, et al.. (2011). Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. The Lancet Infectious Diseases. 12(4). 307–317. 141 indexed citations
17.
Hewer, Raymond, et al.. (2010). Natural Polymorphisms of integrase Among HIV Type 1-Infected South African Patients. AIDS Research and Human Retroviruses. 26(4). 489–493. 29 indexed citations
18.
Papathanasopoulos, Maria A., Eftyhia Vardas, Carole L. Wallis, et al.. (2010). Characterization of HIV Type 1 Genetic Diversity Among South African Participants Enrolled in the AIDS Vaccine Integrated Project (AVIP) Study. AIDS Research and Human Retroviruses. 26(6). 705–709. 10 indexed citations
19.
Hamers, Raph L, Margaret Siwale, Carole L. Wallis, et al.. (2010). HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 95–101. 31 indexed citations
20.
Bundy, Rafe, Ann F. Walker, Richard W. Middleton, Carole L. Wallis, & H. Simpson. (2008). Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: A randomized, double blind placebo controlled trial. Phytomedicine. 15(9). 668–675. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026